证券代码：688393 证券简称：安必平 公告编号：2026-001 广州安必平医药科技股份有限公司 关于自愿披露公司及子公司2025年10-12月获得 资质情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 广州安必平医药科技股份有限公司(以下简称"公司")及子公司在2025年10-12月获得国内医疗器械备案证 9项、知识产权类资质3项，获得境外资质1项。相关信息如下： 一、获得资质的具体情况 （一）获得国内医疗器械备案证情况 2.获得计算机软件著作权登记证书情况 ■ （三）获得境外资质的情况 1.获得专利证书情况 ■ 二、对公司的影响 上述资质的取得，有利于丰富公司的产品种类，完善公司知识产权保护体系，扩充公司在肿瘤筛查与精 准诊断领域的产品布局，增强公司的核心竞争力。 ■ （二）获得知识产权情况 1.获得专利证书情况 ■ 三、风险提示 上述产品的实际销售情况取决于市场的推广效果、品牌综合影响力及市场实际需求等因素，具有较大的 不确定性。敬请广大投资者谨慎投资，注意投资风险。 特此公告。 广州安必平医药科技股份 ...

Market Overview - The tech bubble from 1995 to 2000 was driven by technological advancements, macroeconomic changes, regulatory relaxations, and shifts in monetary policy frameworks[6] - The NASDAQ Composite Index peaked at 5048.62 on March 10, 2000, before a significant sell-off began due to external economic shocks[9] Economic Factors - Labor productivity in the U.S. increased significantly during this period, breaking the long-standing relationship of "low unemployment and high inflation" and contributing to economic resilience[6] - The rapid increase in productivity led to a contraction of the output gap, with inflation remaining subdued despite declining unemployment rates[17] Monetary Policy - The Federal Reserve, under Alan Greenspan, adopted a technology-friendly monetary policy framework, maintaining low interest rates to support economic growth while being cautious about inflation[22] - The Fed's approach evolved to focus on maintaining overall price stability and managing the consequences of asset bubbles rather than attempting to burst them[23] Investment Trends - The number of tech IPOs surged from 1995, peaking in 1999, reflecting a growing investor appetite for technology stocks[9] - In 1998 and 1999, tech stocks experienced a significant rally, with the information technology sector showing returns of 77.64% and 78.44% respectively[32] Risk Factors - The report highlights that excessive liquidity and regulatory relaxation were common characteristics of bubbles, with the potential for chaotic leverage expansion being a critical concern[6] - The experience of the tech bubble serves as a cautionary tale, emphasizing that historical patterns cannot be solely relied upon for future investment decisions[2]

向阳花开，乘势而上——2026 年 A 股年度策略 20251214 摘要 2025 年市场由流动性驱动，万得全 A 指数上涨 25%，估值提升贡献 20%，盈利支撑仅占 5%，主要受益于国家队支撑、险资流入及居民存 款转移等增量资金。 预计 2026 年 PPI 将回升，中性预期下年底或达-0.7 左右，与全 A 非金 融企业盈利增速和 ROE 一致，盈利增速有望达 10%左右。 PPI 弱回升情境下，沪深 300 指数 ERP 可能降至负一倍标准差，对应指 数涨幅约 10%，即从 4,000 点涨至 4,500 点左右。 微观流动性依赖外资和居民存款搬家，外资回流受限，需依赖银行理财 到期及收益率下行吸引居民资金入市，券商启动是关键。 券商板块对引导散户资金入市至关重要，券商股短期快速上涨通常伴随 市场中小单净流入量占比提升，预计 2026 年一季度可能重现。 2026 年一季度是全年确定性最强窗口，政策发力、经济预期乐观、流 动性宽松及事件催化，是布局净值最佳时机，下半年市场或震荡。 春季躁动行情或提前至 2025 年底至 2026 年 1 月上旬，成长风格胜率 高，关注软件、传媒中的游戏、机器人、创新 ...

Core Insights - The report highlights the gradual recovery of the domestic market, with expectations for a 5% growth target for the year, supported by macroeconomic stabilization and upcoming policy meetings that may catalyze a new market rally [5][9][10] - The A-share market is experiencing a phase of consolidation, with various sectors such as aerospace robotics, coal, and non-ferrous metals leading the gains, while others like tourism and food and beverage are lagging [5][9][13] - The report emphasizes the importance of maintaining a balanced investment strategy, focusing on high-dividend defensive stocks and technology growth sectors [10][12] Domestic Market Performance - The Shanghai Composite Index closed at 3,875.79, with a slight decline of 0.06%, while the Shenzhen Component Index rose by 0.40% to 13,006.72 [3] - The average price-to-earnings ratios for the Shanghai Composite and ChiNext indices are 15.94 and 47.66, respectively, indicating a suitable environment for medium to long-term investments [5][9] International Market Performance - Major international indices such as the Dow Jones and S&P 500 experienced declines of 0.67% and 0.45%, respectively, while the Nikkei 225 saw a modest increase of 0.62% [4] Industry Analysis - The report indicates that the charging and swapping service industry, along with information transmission and software services, are experiencing rapid growth in electricity consumption [16] - The coal production and import rates are declining, with a notable decrease in raw coal production by 2.3% year-on-year in October 2025 [17][18] - The report also notes that the chemical industry is gradually entering a recovery phase, with improved profitability in sectors like agricultural chemicals and fluorochemicals, while others face challenges due to overcapacity [21][22] Investment Recommendations - The report maintains a "stronger than the market" rating for the electric power and public utilities sector, suggesting a focus on stable, high-dividend companies [19] - In the chemical industry, it recommends monitoring integrated leaders such as Wanhua Chemical and Baofeng Energy, as well as sectors like organic silicon and phosphoric chemicals for investment opportunities [23][24] - The AI sector is highlighted for its rapid application growth, with recommendations to focus on companies involved in AI infrastructure and domestic chip production [24][25]

Core Viewpoint - Shenzhen Yingfit Technology Co., Ltd. has provided guarantees for its wholly-owned subsidiaries, with the total amount exceeding 100% of the latest audited net assets, raising concerns about potential risks associated with these guarantees [2][15]. Summary by Sections Guarantee Overview - The company approved a guarantee limit of up to RMB 42 million for 2025, with specific allocations for subsidiaries based on their asset-liability ratios: RMB 39.9 million for those above 70% and RMB 2.1 million for those below [3][4]. - The guarantees cover various financing activities, including loans and performance guarantees, and include types such as guarantees, mortgages, and pledges [3][4]. Guarantee Progress and Main Agreement - On November 28, 2025, the subsidiaries signed loan agreements with Beijing Bank for amounts of RMB 9.9535 million, RMB 10 million, RMB 6.52 million, and RMB 10 million, with a one-year term [5]. - The company signed guarantee contracts with Beijing Bank, covering all debts under the loan agreements, including principal, interest, penalties, and related costs [5][6]. Current Guarantee Balances - After the guarantees, the remaining guarantee balances for the subsidiaries are as follows: Yingfit Intelligent - RMB 18.4535 million, Yingfit Renyong - RMB 136.2674 million, Yingfit Software - RMB 7 million, and Yingfit Zhiyuan - RMB 29.06 million [7]. Subsidiary Basic Information - Yingfit Intelligent: Established in 2016, with a registered capital of RMB 10 million, focusing on video surveillance and IoT technology [8]. - Yingfit Renyong: Established in 1999, with a registered capital of RMB 18.285 million, specializing in system integration and technology services [10]. - Yingfit Software: Established in 2008, with a registered capital of RMB 7.6 million, focusing on software development for security and monitoring systems [12]. - Yingfit Zhiyuan: Established in 2019, with a registered capital of RMB 10 million, providing smart city and smart park services [14]. Cumulative Guarantees and Status - As of the announcement date, the total guarantees provided by the company and its subsidiaries amount to RMB 56 million, with a balance of RMB 31.58009 million, representing 180.04% of the latest audited net assets [15].

Core Viewpoints - Current risk release provides an opportunity for reallocating A-shares and Hong Kong stocks by year-end and planning for 2026 [2] - The AI sector is experiencing a "darkest hour," but long-term confidence remains unwavering [4] - The adjustment phase is merely a "doubtful bull market level" [11] Industry Insights - Focus on resource and traditional manufacturing opportunities, particularly in chemicals, non-ferrous metals, and new energy [3] - The AI industry is expected to continue its growth trajectory, with significant valuation growth potential for A-share companies [8] - The market is likely to experience a style switch, with increasing attention on low-valued sectors [6] Investment Recommendations - Emphasize sectors benefiting from physical asset consumption, such as upstream resources (copper, aluminum, lithium, oil, coal) and midstream industries [5] - Maintain a balanced allocation between growth sectors and undervalued value industries, particularly in the consumer sector as year-end approaches [10] - Focus on AI applications and sectors closely related to the "14th Five-Year Plan," such as hydrogen energy, nuclear energy, and quantum technology [14]

Core Viewpoint - Zhongke Soft's stock price has experienced a decline of 1.45% year-to-date, with a recent drop of 2.01% on November 19, 2023, indicating potential challenges in market performance [1]. Financial Performance - For the period from January to September 2025, Zhongke Soft reported a revenue of 4.415 billion yuan, reflecting a year-on-year growth of 7.04%. However, the net profit attributable to shareholders decreased by 40.18% to 173 million yuan [2]. - Cumulatively, since its A-share listing, Zhongke Soft has distributed a total of 1.728 billion yuan in dividends, with 977 million yuan distributed over the past three years [3]. Shareholder and Market Activity - As of October 31, 2025, the number of shareholders for Zhongke Soft increased to 65,400, a rise of 0.47%. The average number of circulating shares per person decreased by 0.47% to 12,697 shares [2]. - The stock's trading activity on November 19 showed a net outflow of 11.36 million yuan in principal funds, with significant selling pressure from large orders [1]. Company Overview - Zhongke Soft, established on May 30, 1996, and listed on September 9, 2019, is based in Haidian District, Beijing. The company specializes in computer software development, with its main revenue sources being software development and services (71.83%) and system integration services (26.63%) [1]. - The company operates within the computer software development industry, specifically in vertical application software, and is associated with various concepts including MSCI China, margin financing, cloud computing, internet healthcare, and blockchain [1].

Core Points - Zhengzhou Jiean High-tech Co., Ltd. has completed the registration change and obtained a new business license, with registered capital officially changed to 205.052707 million yuan (approximately 20.5 million) [1] - The change in registered capital was approved during the 19th meeting of the fifth board of directors on September 28, 2025, and subsequently ratified by the first extraordinary general meeting of shareholders on October 17, 2025 [1] - The company's core business remains focused on computer software, mechatronic equipment research and sales, and related technical services, with no changes to its operational scope or legal representative [2] Company Information - The company is a publicly listed limited liability company, established on June 3, 2002, with its registered address in Zhengzhou High-tech Industrial Development Zone [2] - The business scope includes computer network technology services, software development, mechatronic equipment sales, and various engineering services [2] - The adjustment in registered capital is expected to optimize the company's capital structure and support ongoing business development [2]

Company Overview - Zhongke Ruankong Technology Co., Ltd. is located in Haidian District, Beijing, and was established on May 30, 1996. The company was listed on September 9, 2019. Its main business involves computer software development, sales, and services [1]. - The company's revenue composition includes 71.83% from software development and services, 26.63% from system integration and services, 1.29% from software products, and 0.26% from other sources [1]. Financial Performance - As of September 30, 2025, Zhongke Ruankong achieved operating revenue of 4.415 billion yuan, representing a year-on-year growth of 7.04%. However, the net profit attributable to shareholders decreased by 40.18% to 173 million yuan [2]. - The company has distributed a total of 1.728 billion yuan in dividends since its A-share listing, with 977 million yuan distributed over the past three years [3]. Stock Market Activity - On November 6, Zhongke Ruankong's stock price increased by 2.24%, reaching 22.35 yuan per share, with a trading volume of 260 million yuan and a turnover rate of 1.42%. The total market capitalization is 18.574 billion yuan [1]. - Year-to-date, the stock price has risen by 4.88%, with a 3.33% increase over the last five trading days, a 5.23% increase over the last 20 days, and a 10.26% increase over the last 60 days [1]. Shareholder Information - As of September 30, 2025, the number of shareholders is 65,100, a decrease of 2.19% from the previous period. The average number of circulating shares per person increased by 2.24% to 12,756 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fifth largest, holding 9.6235 million shares, an increase of 3.1576 million shares from the previous period. The Huabao CSI Financial Technology Theme ETF is the sixth largest shareholder, holding 9.4231 million shares as a new shareholder [3].

Core Points - The company has obtained a total of 4 domestic patent certificates, including 2 invention patents and 2 design patents, as well as 2 foreign patents, 3 computer software copyright registration certificates, and 1 Class I medical device filing certificate from July 1, 2025, to September 30, 2025 [1][2][3] Group 1: Patent Certificates - The acquisition of the patents reflects the company's core technology and will enhance its intellectual property protection system, promoting technological innovation and improving core competitiveness [1][2] - The recent patent acquisitions are not expected to have a significant impact on the company's short-term operations [1][2] Group 2: Computer Software Copyright - The obtained computer software copyright registration certificates will help enhance the company's core competitiveness and support the establishment of a continuous innovation mechanism [2] Group 3: Medical Device Filing - The Class I medical device filing certificate will diversify the company's product offerings and meet market demand, thereby strengthening its core competitiveness [3] - The sales performance of the products post-launch will depend on future market promotion efforts, and the company cannot currently predict the specific impact on future revenue [3]